ONC
BeOne Medicines Ltd
225 hedge funds and large institutions have $10.4B invested in BeOne Medicines Ltd in 2024 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 52 increasing their positions, 87 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
14% more funds holding
Funds holding: 197 → 225 (+28)
0.02% less ownership
Funds ownership: 3.75% → 3.73% (-0.02%)
40% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 87
Holders
225
Holding in Top 10
10
Calls
$66.1M
Puts
$27.3M
Top Buyers
| 1 | +$95.9M | |
| 2 | +$64.2M | |
| 3 | +$45M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$36.5M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$31.2M |
Top Sellers
| 1 | -$140M | |
| 2 | -$131M | |
| 3 | -$51.7M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$49.9M |
| 5 |
AG
Artal Group
Luxembourg
|
-$43.3M |